Fidelius von Rehlingen-Prinz
Manager
Fidelius von Rehlingen-Prinz is a German physician–scientist, orthopedic surgeon, and health‑tech advisor working at the intersection of academic medicine and technological innovation. He studied medicine at FAU Erlangen–Nürnberg, where he also earned a PhD (Dr. med.) with research on cell‑signaling pathways in multiple myeloma. He completed his residency in Orthopedics and Traumatology at the University Hospital Hamburg, and further trained at the Hospital for Special Surgery (HSS) in New York, where he also contributed to resident and medical student teaching at Weill Cornell Medicine. Alongside his clinical career, he is currently completing an MBA at the Quantic School of Business and Technology, focusing on strategic leadership and innovation in healthcare. Fidelius plays an active role in both the German and U.S. health‑tech ecosystems as a medical advisor to startups and companies, with work spanning diagnostics, digital health, and clinical AI. He has served as a jury member and expert reviewer for the Berlin Institute of Health at Charité and for organizations advancing the digitalization of orthopedics and traumatology. Now living in the United States, he is a co‑founder of Oxbridge Clinical, a company developing a rapid, portable diagnostic platform capable of identifying bacterial, viral, and fungal pathogens in under ten minutes, with antibiotic‑resistance profiling delivered within hours. Built around accessible hardware, recurring consumables, and AI‑driven analysis, the platform supports clinical, food safety, and industrial settings where fast, decentralized microbiological testing is essential.
University: FAU Erlangen–Nürnberg, University Hospital Hamburg, Hospital for Special Surgery / Weill Cornell Medicine, Quantic School of Business and Technology